Cerebrospinal Fluid (CSF) Management Market
Cerebrospinal Fluid (CSF) Management Market (Product - CSF Shunts and CSF Drainage Systems) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023
Global Cerebrospinal Fluid (CSF) Management Market: Snapshot
When there is an imbalance between the production and absorption of cerebrospinal fluid (CSF), is known as hydrocephalus. Surplus production of CSF, obstruction of circulation, faulty absorption, or brain atrophy are the key reasons that lead to an increase in CSF. The surplus CSF is saved in subarachnoid spaces of the brain or within the ventricles, and is also known as hydrodynamic CSF disorder. The prevalence of hydrocephalus is mostly seen among the babies at the time of birth but can also be seen in elderly people. If it occurs to a neonatal, it can physically deform the child because CSF continues to build up that leads to expansion of child’s head to accommodate excessive CSF. As compared to the older child or an elderly, the infant head can expand, as their fontanels are not yet closed. Thus, in case if hydrocephalus is left without treating it can be a cause of mental retardation because of the high pressure being applied on nearby tissues causing the brain to atrophy. In addition, increasing cases of neonatal infections and neural tube defects in emerging economies are related to advanced rates of hydrocephalus.
As per TMR, the global cerebrospinal fluid management market is prophesied to rise at 5.5% CAGR during the forecast tenure from 2015 to 2023. The valuation for the market is expected to touch US$ 1.84 bn by the end of 2023 progressing from US$1.13 as estimated in 2014.
Rising Neurological Diseases to Fuel Market Growth
The global cerebrospinal fluid management market is classified on the basis of type of product that is further segmented into CSF drainage system and CSF shunts. CSF drainage system has been further bifurcated into the lumbar drainage system and ventricular drainage system. The CSF shunts segment held major share in the market in 2014. Nevertheless, the CSF drainage systems segment is expected to rise at high CAGR over the forecast period. This growth is attributed to the growing prevalence of neurological diseases among the general population. In addition to that, rising geriatric population diagnosed with neurological diseases such as Parkinson’s and Alzheimer’s disease, growing demand for minimally invasive surgeries, and high funding by private organizations and government are likely to drive the CSF market in the coming years.
Rapid Technological Innovation to boost demand for Cerebrospinal Fluid Management in Developed Economies
On the regional front, the global cerebrospinal fluid management market includes North America, Asia Pacific, Europe, Latin America, and the Rest of the World. Among these regions, North America held the largest share in the market in 2014. During the forecast period, the region is expected to continue its dominance due to rapid technological innovations and increasing geriatric population. On the other hand, Asia Pacific projected to witness high growth over the forecast period between 2015 and 2023. This is mainly because of rising geriatric population, growing demand for minimally invasive surgeries, and increasing medical tourism in emerging economies. However, the high cost of surgical procedures and lack of availability of shunts in developing countries may obstruct the growth of the market in these countries.
But these restraining factors are projected to be reduced with improving healthcare infrastructure and economic development in emerging nations. Rising disposable income that will increase the purchasing power of the people in countries like India, China, and Brazil will also benefit the market growth. Moreover, increasing medical expenditure by governments has also created huge opportunities for the CSF market to grow the emerging economies.
The report has also analyzed some of the major player contributing to the cerebrospinal fluid management market. Medtronic plc, B. Braun Melsungen AG, DePuy Synthes (a J & J Company), Spiegelberg GmbH & Co. KG, Sophysa S.A., and Integra LifeSciences Holding Corporation are some of the leading players in the market.
Techniques in Cerebrospinal Fluid (CSF) Management Market to Gain Clinical Acceptance for Managing Chronic Conditions
The clinical analysis of cerebrospinal fluid (CSF) has become crucial in assessing various neurological diseases. CSF is a clear fluid that moves around and within the organs of central nervous system notably in intracranial and spinal compartments. At any given point in time, 125 mL to 150 mL of CSF is present in the human body, and it goes frequent generation and reabsorption. Choroid plexus produces the major source while the ependymal cells produces the minority one. The composition and quantity of CSF is thus a vital indicator of diagnosis and severity of various neurological conditions, which is a key factor propelling investments in cerebrospinal fluid (CSF) management market. Growing relevance of initiating therapeutic measures based on CSF management has only expanded the horizon for companies in the market. Various techniques to time the lumbar puncture (LP), and advances made in microbiological evaluation have resulted in generating strides in the CSF management. Some of the acute brain conditions where CSF analysis is useful are subarachnoid hemorrhage (SAH) and meningitis or meningoencephalitis. Over the years, CSF analysis has become a useful diagnostic, therapeutic, and prognostic tool in managing demyelinating diseases, particularly helping in understanding of progress of the autoimmune diseases.
The COVID-19 pandemic arising out of the infectious virus has inflicted high mortality and morbidity in affected patient population over the past few months worldwide. The peaks and outbreaks have concerned industries, epidemiologists, policy makers, and the general population at unpredended scale. Though the vaccination programs have started in some countries and picked up pace in others in recent months, the health and economic uncertainties are still persistent. People with cardiovascular disease (CVD), chronic respiratory disease, cancer, and diabetes have been high-risk populations, with young and adult patient populations at the forefront of the vaccination programs. People with neurological diseases are expected to undergo various CSF techniques in coming years. The trend can be ascribed to the rise in elderly population suffering with chronic neurological conditions and the growing adoption of patient engagement models by healthcare providers.
Hydrocephalus is defined as an abnormal increase in the amount of cerebrospinal fluid inside the cranial cavity accompanied with enlargement of cerebral ventricles, which frequently leads to intracranial pressure and skull enlargement. Hydrocephalus majorly affects population aged 50 years and above. According to the World Population Prospects: the 2012 Revision (United Nations, Department of Economic and Social Affairs), the age group above 80 years, also referred as ‘oldest old’ in the report, was nearly 14% and is expected to increase to 19% by 2050. Earlier the treatment for hydrocephalus consisted of purging, bleeding, and puncturing of the ventricles to drain the fluid, surgical removal of fluid, application of cold wraps or plaster of herbs to the head, etc. There is no effective treatment for hydrocephalus. Diuretics such as Acetazolamide are medications prescribed to few hydrocephalus patients; however, these are temporary treatments. Hydrocephalus was considered a serious problem by neurosurgeons until the development of shunt valve. This transformed the quality of care for patients with hydrocephalus.
This report on the global CSF management market analysis the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. This section also provides the overall information and data analysis of the global CSF management market with respect to the leading market segments based on type of product and geography.
The market overview section of the report includes qualitative analysis of the CSF management market including the factors determining the market dynamics such as drivers, restraints, and opportunities along with Porter’s Five Forces Analysis. In addition, various analyses such as market attractiveness analysis by geography and competitive landscape by key players have been provided. The market attractiveness analysis explains the intensity of competition in the market in different regions. The competitive scenario between market players is evaluated through market share analysis. These factors would help market players to take strategic decisions in order to strengthen their positions and expand their share in the global market.
The global CSF management market has been segmented based on type of product and geography. Based on type of product, the CSF management market has been categorized into two segments: CSF shunts and CSF drainage systems. CSF drainage system has been further classified into ventricular drainage system and lumbar drainage system. Market revenue in terms of US$ Mn for the period between 2013 and 2023 along with the compound annual growth rate (CAGR %) from 2015 to 2023 are provided for all the segments, considering 2014 as the base year.
Geographically, the CSF management market has been categorized into five regions: North America, Europe, Asia Pacific, Latin America, and Rest of the World (RoW). North America comprises the U.S. and Canada. Europe includes Germany, the U.K., France, and Rest of Europe. Asia-Pacific comprises China, Japan, and Rest of Asia-Pacific. Latin America consists of Brazil and Rest of Latin America. Rest of the World includes South Africa and Rest of Rest of the World. The recommendations section included in the report would assist existing players to expand their market share and new companies to establish their presence in the CSF management market. The report also profiles major players in the CSF management market based on various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players profiled in this report include DePuy Synthes (a J & J Company), Medtronic plc, B. Braun Melsungen AG, Sophysa S.A., Spiegelberg GmbH & Co. KG, Integra LifeSciences Holding Corporation, BeckerSmith Medical, Inc., and Möller Medical GmbH.
The global CSF management market has been segmented as follows:
Global CSF Management Market, by Product
- CSF Shunts
- CSF Drainage Systems
- Ventricular Drainage System
- Lumbar Drainage System
Global CSF Management Market, by Geography
- North America
- Rest of Europe
- Asia-Pacific (APAC)
- Rest of APAC
- Latin America
- Rest of Latin America
- Rest of the World
- South Africa
- Rest of Rest of the World